Ticker Details
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals.
IPO Date:	July 18, 2013
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$1.75B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.93 | 2.03%
Avg Daily Range (30 D):	$1.40 | 1.72%
Avg Daily Range (90 D):	$1.35 | 1.61%

Institutional Daily Volume
Avg Daily Volume:	.15M
Avg Daily Volume (30 D):	.36M
Avg Daily Volume (90 D):	.31M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	2,435
Avg Institutional Trade:	$2.19M
Avg Institutional Trade (30 D):	$3.26M
Avg Institutional Trade (90 D):	$3.99M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.58M
Avg Closing Trade (30 D):	$4.92M
Avg Closing Trade (90 D):	$4.51M
Avg Closing Volume:	41.08K

News

Feb 13, 2026 @ 11:50 AM ANI Pharmaceuticals to Discuss Fourth Quarter and ... Source: Na

Dec 28, 2025 @ 5:26 PM ANI Stock Is Up 49% This Past Year, Revenue Is Sur... Source: Jonathan Ponciano

Aug 29, 2025 @ 12:00 PM CG Oncology’s Executive Leadership to Parti... Source: Cg Oncology

Aug 8, 2025 @ 12:25 PM Cg Oncology (CGON) Q2 Loss Widens 93% Source: Jesterai

May 12, 2025 @ 10:30 PM ANI Pharmaceuticals to Participate at the H.C. Wai... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$1.71	$1.19	$.37
Diluted EPS	$1.6	$1.13	$.36
Revenue	$826.88M	$227.81M	$211.37M
Gross Profit
Net Income / Loss	$40.57M	$26.62M	$8.55M
Operating Income / Loss	$71.95M	$36.24M	$13.89M
Cost of Revenue
Net Cash Flow	$117.63M	$44.81M	$68M
PE Ratio	47.94

Splits
Jul 18, 2013	1:6
Jun 04, 2012	1:6
Jun 03, 2002	1:10